Improvements in Vertebral Body Strength Under Teriparatide Treatment Assessed In Vivo by Finite Element Analysis: Results From the EUROFORS Study

Monitoring of osteoporosis therapy based solely on DXA is insufficient to assess antifracture efficacy. Estimating bone strength as a variable closely linked to fracture risk is therefore of importance. Finite element (FE) analysis–based strength measures were used to monitor a teriparatide therapy...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of bone and mineral research 2009-10, Vol.24 (10), p.1672-1680
Hauptverfasser:	Graeff, Christian, Chevalier, Yan, Charlebois, Mathieu, Varga, Peter, Pahr, Dieter, Nickelsen, Thomas N, Morlock, Michael M, Glüer, Claus C, Zysset, Philippe K
Format:	Artikel
Sprache:	eng
Schlagworte:	Biological and medical sciences Biomechanical Phenomena - drug effects Bone Density - drug effects Bone Density Conservation Agents - pharmacology bone strength Densitometry Europe Female Finite Element Analysis Fundamental and applied biological sciences. Psychology Humans Organ Size - drug effects osteoporosis Skeleton and joints Spine - drug effects Spine - pathology Spine - physiopathology teriparatide Teriparatide - pharmacology Time Factors Treatment Failure Vertebrates: osteoarticular system, musculoskeletal system
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!